Nektar's IL-2 Impresses In Combination With Bristol's Opdivo

 
• By Emily Hayes
  
T-cells attacking cancer_1200x675
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer